Sulforaphane inhibits HDAC activity in prostate cancer cells, retards growth of PC3 xenografts, and inhibits HDAC activity in vivo
Conference Paper
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- Other
-
- View All
-
Overview
published proceedings
author list (cited authors)
-
Myzak, M. C., Hardin, K., Yan, M., Tong, P., Dashwood, R., & Ho, E.
citation count
complete list of authors
-
Myzak, MC||Hardin, K||Yan, M||Tong, P||Dashwood, R||Ho, E
publication date
publisher
published in
Research
keywords
-
32 Biomedical And Clinical Sciences
-
3211 Oncology And Carcinogenesis
-
5 Development Of Treatments And Therapeutic Interventions
-
5.1 Pharmaceuticals
-
Aging
-
Biotechnology
-
Cancer
-
Complementary And Integrative Health
-
Nutrition
-
Prevention
-
Prostate Cancer
-
Urologic Diseases
Identity
Digital Object Identifier (DOI)
Additional Document Info
start page
end page
volume
issue
Other
URL
-
http://dx.doi.org/10.1096/fasebj.20.4.a150